These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 18583976)
1. Conflicting evidence on the frequency of ESR1 amplification in breast cancer. Albertson DG Nat Genet; 2008 Jul; 40(7):821-2. PubMed ID: 18583976 [No Abstract] [Full Text] [Related]
2. ESR1 gene amplification in breast cancer: a common phenomenon? Reis-Filho JS; Drury S; Lambros MB; Marchio C; Johnson N; Natrajan R; Salter J; Levey P; Fletcher O; Peto J; Ashworth A; Dowsett M Nat Genet; 2008 Jul; 40(7):809-10; author reply 810-2. PubMed ID: 18583966 [No Abstract] [Full Text] [Related]
3. ESR1 gene amplification in breast cancer: a common phenomenon? Horlings HM; Bergamaschi A; Nordgard SH; Kim YH; Han W; Noh DY; Salari K; Joosse SA; Reyal F; Lingjaerde OC; Kristensen VN; Børresen-Dale AL; Pollack J; van de Vijver MJ Nat Genet; 2008 Jul; 40(7):807-8; author reply 810-2. PubMed ID: 18583965 [No Abstract] [Full Text] [Related]
4. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Holst F; Stahl PR; Ruiz C; Hellwinkel O; Jehan Z; Wendland M; Lebeau A; Terracciano L; Al-Kuraya K; Jänicke F; Sauter G; Simon R Nat Genet; 2007 May; 39(5):655-60. PubMed ID: 17417639 [TBL] [Abstract][Full Text] [Related]
5. ESR1 amplification in endometrial carcinomas: hope or hyperbole? Tan DS; Lambros MB; Marchiò C; Reis-Filho JS J Pathol; 2008 Nov; 216(3):271-4. PubMed ID: 18788074 [TBL] [Abstract][Full Text] [Related]
6. Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study. Ooi A; Inokuchi M; Harada S; Inazawa J; Tajiri R; Kitamura SS; Ikeda H; Kawashima H; Dobashi Y J Pathol; 2012 May; 227(1):8-16. PubMed ID: 22170254 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation. Lin CH; Liu JM; Lu YS; Lan C; Lee WC; Kuo KT; Wang CC; Chang DY; Huang CS; Cheng AL J Clin Pathol; 2013 Feb; 66(2):140-5. PubMed ID: 23268322 [TBL] [Abstract][Full Text] [Related]
8. ESR1 gene amplification in breast cancer: a common phenomenon? Vincent-Salomon A; Raynal V; Lucchesi C; Gruel N; Delattre O Nat Genet; 2008 Jul; 40(7):809; author reply 810-2. PubMed ID: 18583967 [No Abstract] [Full Text] [Related]
9. ESR1 gene amplification in breast cancer: a common phenomenon? Brown LA; Hoog J; Chin SF; Tao Y; Zayed AA; Chin K; Teschendorff AE; Quackenbush JF; Marioni JC; Leung S; Perou CM; Neilsen TO; Ellis M; Gray JW; Bernard PS; Huntsman DG; Caldas C Nat Genet; 2008 Jul; 40(7):806-7; author reply 810-2. PubMed ID: 18583964 [No Abstract] [Full Text] [Related]
10. ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous. Moelans CB; Holst F; Hellwinkel O; Simon R; van Diest PJ PLoS One; 2013; 8(12):e84189. PubMed ID: 24367641 [TBL] [Abstract][Full Text] [Related]
11. Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer. Soysal SD; Kilic IB; Regenbrecht CR; Schneider S; Muenst S; Kilic N; Güth U; Dietel M; Terracciano LM; Kilic E Breast Cancer Res Treat; 2015 Jun; 151(3):709-15. PubMed ID: 25981900 [TBL] [Abstract][Full Text] [Related]
13. Absence of ESR1 amplification in a series of breast cancers. Adélaïde J; Finetti P; Charafe-Jauffret E; Wicinski J; Jacquemier J; Sotiriou C; Bertucci F; Birnbaum D; Chaffanet M Int J Cancer; 2008 Dec; 123(12):2970-2. PubMed ID: 18816632 [No Abstract] [Full Text] [Related]
14. Gene amplification in ductal carcinoma in situ of the breast. Burkhardt L; Grob TJ; Hermann I; Burandt E; Choschzick M; Jänicke F; Müller V; Bokemeyer C; Simon R; Sauter G; Wilczak W; Lebeau A Breast Cancer Res Treat; 2010 Oct; 123(3):757-65. PubMed ID: 20033484 [TBL] [Abstract][Full Text] [Related]
16. Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions. Lebeau A; Grob T; Holst F; Seyedi-Fazlollahi N; Moch H; Terracciano L; Turzynski A; Choschzick M; Sauter G; Simon R J Pathol; 2008 Oct; 216(2):151-7. PubMed ID: 18720455 [TBL] [Abstract][Full Text] [Related]
17. Clinical and Biological Significance of Nagel A; Szade J; Iliszko M; Elzanowska J; Welnicka-Jaskiewicz M; Skokowski J; Stasilojc G; Bigda J; Sadej R; Zaczek A; Markiewicz A Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995757 [TBL] [Abstract][Full Text] [Related]
18. ESR1 gene amplification in endometrial carcinomas: a clinicopathological analysis. Rahman MT; Nakayama K; Rahman M; Ishikawa M; Katagiri H; Katagiri A; Ishibashi T; Sato E; Iida K; Ishikawa N; Nakayama N; Miyazaki K Anticancer Res; 2013 Sep; 33(9):3775-81. PubMed ID: 24023309 [TBL] [Abstract][Full Text] [Related]
19. Detection of Gene Amplification by Multiplex Ligation-Dependent Probe Amplification in Comparison with In Situ Hybridization and Immunohistochemistry. Tabarestani S; Ghaderian SM; Rezvani H Asian Pac J Cancer Prev; 2015; 16(17):7997-8002. PubMed ID: 26625832 [TBL] [Abstract][Full Text] [Related]
20. Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer. Nielsen KV; Ejlertsen B; Müller S; Møller S; Rasmussen BB; Balslev E; Lænkholm AV; Christiansen P; Mouridsen HT Breast Cancer Res Treat; 2011 Jun; 127(2):345-55. PubMed ID: 20556506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]